We are delighted to announce that the Cancer Research UK Cambridge Centre has been re-accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI) for a further 5 years.
This is a prestigious designation which is only given to the top 20 Cancer Centres in Europe, including NKI in Amsterdam, L'Institut Curie and Gustave Roussy in Paris, and the Christie in Manchester.
The accreditation covers both the quality of the clinical cancer services in Cambridge University Hospitals (CUH) and Royal Papworth Hospital, and all the research and educational activities of the CRUK Cambridge Centre, from basic to clinical research.
The peer review process, which took place in July 2019, involved 37 separate interviews and department visits, and engaged more than 90 staff and patients.
Simon Oberst, Director of Clinical Development of the Cancer Research UK Cambridge Centre, said: “The Report from OECI particularly commends the quality of multidisciplinary team working and leadership of the CUH Cancer Services, and also the involvement of patients in the co-creation of services through the Cancer Patient Partnership Group.
“It describes the Centre’s cancer research as world-class, strikingly innovative, and ambitiously collaborative across disciplines.”
CRUK Cambridge Centre leaders applauded all the clinicians, researchers, and administrators who helped make the peer review another success.